COVID-19 and the Cardiovascular System

Brian Case, MD, FACC, FSACI is an Interventional Cardiologist at MedStar Heart and Vascular Institute, working at MedStar Washington Hospital Center, MedStar Georgetown University Hospital and MedStar Southern Maryland Hospital. He is the Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at MedStar Southern Maryland Hospital. He holds an appointment of Assistant Professor of Medicine, Georgetown University. He is board certified in interventional cardiology, cardiovascular disease and internal medicine with extensive fellowship training. He is also an associate editor of the Cardiovascular Revascularization Medicine Journal. He has as written over ten first author manuscripts on original data evaluating the impact of the COVID-19 on the cardiovascular system. This includes clinical outcomes, therapeutic options, and the role of the COVID-19 vaccine on outcomes. He has also written several editorials and review papers on the topic. His work has been presented at multiple national cardiology conference. His healthcare center (MedStar) has been a contributing site to the North American COVID-19 Myocardial infarction Registry, which is a national, multi-site registry evaluating patients with COVID-19 presenting with ST-elevation myocardial infarction. The registry has already published multiple manuscripts with plans to continue this work. Ron Waksman, MD, FACC, FESC, MSCAI, is a distinguished Professor of Cardiology at Georgetown University, Associate Director of Cardiology at MedStar Washington Hospital Center, and Director of Cardiovascular Research and Advanced Education at MedStar Health. A globally recognized interventional cardiologist, he has been Principal Investigator for over 230 clinical studies. He is Editor-in-Chief of the Journal Cardiovascular, Revascularization Medicine, and is founder and chair of the Cardiovascular Research Technology meeting. He is credited on 15 patents in vascular brachytherapy, covered stents, leaflet valve modification, and balloon technology. His research interests include brachytherapy for restenosis prevention, stent technology, biodegradable scaffolds, HDL therapy, vulnerable plaque, intracoronary imaging, structural heart disease, cardiovascular pharmacotherapy, and chronic total occlusion intervention. Dr. Waksman's scholarly contributions include over 1000 published manuscripts, over 16 edited textbooks, and 47 book chapters. He is also founder and Editor-in-Chief of the CRTonline and the CardioTube websites.

1. Foreword
2. Introduction/Epidemiology
3. Pathophysiology of COVID-19
4. Risk Factors/Special Populations
5. Pathophysiology of COVID-19 and the Heart
6. Cardiac Clinical Manifestation
7. Non-Invasive Diagnostic Evaluation
8. Invasive Diagnostic Evaluation
9. Acute and Long-Term Treatment Options
10. Acute Clinical Outcome/Prognosis
11. Long Term Clinical Outcomes/Prognosis
12. Impact of COVID-19 on Heart Failure Patients and Valvular Heart Patients.
13. Emerging Therapeutic Options
14. The Role of COVID-19 Vaccine
15. Prologue